Based on the in vivo and in vitro data, we concluded that OSMR deficiency could contribute to the development of pressure overload-induced cardiac hypertrophy by modulating macrophage function and the OSM/LIFR/STAT3 signalling pathway (see Fig. 11). The gene discussed is STAT3; the disease is cardiac hypertrophy.